Feskov Human Reproduction Group
Feskov Human Reproduction Group
Scoring methodology
Each dimension 1–5, based on public signals; first-party claims are excluded from objective scoring.
- Compliance
- 2.0
- Medical level
- 3.5
- Transparency
- 3.5
- Reputation
- 1.0
- Intl. accessibility
- 4.5
See the Methodology.
Strengths
Not foundConcerns
Not foundControversies & risks
- Documented controversy/risk on record — see Sources (full detail in the Chinese edition).
Score context: vs. peers in this country
Each dimension compared with the average of clinics we cover in the same country; “verified data points” are the public signals behind the score.
Ranked #15 by overall score among the 19 Ukraine providers we cover.
- Accreditations listed: MoH licence No.282411
- 1 controversy record(s)
- Founded: 1995
- Specialties: Surrogacy, Egg donation, IVF, PGT
- Pricing disclosed
- No success rate published
- Third-party rating: Facebook 88% , WhatClinic 7.1
- Accepts Chinese clients: Yes
- Chinese-language service: Yes
Unavailable. Due to the ongoing Russia–Ukraine war (closed airspace, high safety/evacuation risk), we mark Ukrainian clinics as unavailable.
Feskov Human Reproduction Group — Kharkiv (near front, high risk). Specialties: Surrogacy, Egg donation, IVF, PGT. Independent ratings and reputation have not yet been verified by us; see Sources. A documented controversy/risk is on record — see Sources.
Multi-platform reputation scan (2026-07)
- Criminal case, no known verdict. Ukrainian prosecutors indicted founder Oleksandr Feskov and five associates for human trafficking (Art. 149 §3) over "Operation Spaniard": vulnerable Ukrainian women were recruited as surrogates and sent to give birth in Prague, where about 30 newborns were handed to foreign clients (Sweden, Germany, Spain, Greece and others) for roughly €60,000 each; one child reportedly went untraced in the USA. The indictment reached court in 2023; as of 2026-07-04, searches in English, Ukrainian, Russian and Czech found no public record of a trial opening or verdict. Czech authorities declined to prosecute for lack of an applicable offence. Source: Seznam Zprávy.
- No US class action found. We found no record of any class action or civil suit by American clients against Feskov; only older individual complaints (Feskov / La Vita Felice, incl. a claimed $17,000 loss) on the Legal Junkies forum (unverified).
- "Kyiv/Prague relocation" reality check. The About page still claims clinics in Kharkiv, Kyiv and Prague, but the contacts page lists no Prague address, and Feskov's own Czech-program page (Feb 2026) concedes surrogacy in Czechia is "practically impossible" for foreigners, redirecting clients to "hybrid" births in Greece, Armenia and elsewhere. The Brussels "office" (Rond-Point Schuman 2-4, level 6) is a Regus/DaVinci virtual-office floor, suggesting the European offices are marketing addresses. The Kharkiv and Kyiv clinics still take bookings via feskov.ua; Spanish outlet La Marea (Apr 2025) confirmed ongoing wartime operations, mail-in genetic material, and market expansion toward China and Arab countries.
- Regulatory pressure. In early 2025 Spain's Women's Institute named Feskov among 12 companies allegedly breaching the surrogacy-advertising ban (it was left out of the July 2025 lawsuit); Spanish prosecutors moved in Feb 2026 to block foreign surrogacy websites. Ukraine's government drafted a bill (Oct 2025) to ban surrogacy for foreigners.
- Reviews. Trustpilot holds at about 4.0 from 17 reviews, incl. a Dec 2025 positive review and one alleging dishonesty about where surrogates are sourced. A notable 2022 Otzovik review by a prospective Kharkiv surrogate described the Czech birth scheme as criminal "human trafficking" — a year before prosecutors said the same. No indexed Reddit discussions. The Chinese-language site surrogate-mother.cn remains active (updated June 2026), selling €37,500–95,000 "remote packages" with "100% guarantee" wording and no mention of the criminal case.
Pre-contract due-diligence checklist
The top half is what we have verified from public signals; the bottom half is what you should verify yourself.
Verified by us (as of last-verified date)
- International accreditation · Verified
MoH licence No.282411 - Price transparency · Verified
self-reported approx. $20,000 +, $30,000–50,000+ - Success-rate claims · Not found
Not published; ask for live-birth rates by age - Third-party reputation · Verified
Facebook 88% , WhatClinic 7.1 - Controversy records · Caution
1 record(s) — see “Controversies” above - Current availability · Caution
Due to the ongoing Russia–Ukraine war (closed airspace, high safety/evacuation risk), we mark Ukrainian clinics as unavailable.
Verify yourself
- Have the contract reviewed by an independent lawyer (not one referred by the provider)
- Ask for live-birth rates by age bracket, not a headline “success rate”
- Request an itemised fee schedule; confirm currency and refund terms
- Confirm ownership, transfer and disposal terms for medical records and embryos
- If possible, visit the clinic, lab and ward in person before signing
Reviews
To be verified
Frequently asked questions
Answers are based solely on information we have verified, with a last-verified date; not medical or legal advice.
Q1.Does Feskov Human Reproduction Group accept Chinese clients?
Per public information, yes. Chinese-language service is offered. (last verified 2026-07-04)
Q2.How much does Feskov Human Reproduction Group cost?
Publicly listed range: self-reported approx. $20,000 +, $30,000–50,000+. Request an itemised written quote before signing. (last verified 2026-07-04)
Q3.Are Feskov Human Reproduction Group's success-rate claims reliable?
No success rate is published. Ask for live-birth rates by age bracket and their methodology. (last verified 2026-07-04)
Q4.What accreditations does Feskov Human Reproduction Group hold?
Listed: MoH licence No.282411. Verify certificates directly before signing. (last verified 2026-07-04)
Q5.How does this site review Feskov Human Reproduction Group?
Five independent 1–5 scores (compliance, medical quality, transparency, reputation, international accessibility) based only on public signals and third-party feedback; self-descriptions don't count toward objective items. We charge providers nothing. See the Methodology page.